These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 18061845

  • 1. Proteomics and diabetic nephropathy.
    Merchant ML, Klein JB.
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [Abstract] [Full Text] [Related]

  • 2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT, Nagalla SR.
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of kidney proteins in streptozotocin-induced diabetic rats in response to hypoglycemic fungal polysaccharides.
    Hwang HJ, Baek YM, Kim SW, Kumar GS, Cho EJ, Oh JY, Yun JW.
    J Microbiol Biotechnol; 2007 Dec; 17(12):2005-17. PubMed ID: 18167449
    [Abstract] [Full Text] [Related]

  • 5. Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation.
    Diao WF, Chen WQ, Wu Y, Liu P, Xie XL, Li S, Shen PP, Ji J.
    Proteomics; 2006 Nov; 6(21):5837-45. PubMed ID: 17022097
    [Abstract] [Full Text] [Related]

  • 6. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF, Haab BB, Hanash SM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 05; 815(1-2):275-84. PubMed ID: 15652816
    [Abstract] [Full Text] [Related]

  • 7. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S, Rajput A, Kumar Y, Uppuluri N, Arvind AS, Tatu U.
    J Assoc Physicians India; 2005 Jun 05; 53():513-20. PubMed ID: 16121805
    [Abstract] [Full Text] [Related]

  • 8. Proteomic methods for biomarker discovery in urine.
    Wilkey DW, Merchant ML.
    Semin Nephrol; 2007 Nov 05; 27(6):584-96. PubMed ID: 18061841
    [Abstract] [Full Text] [Related]

  • 9. Differential serum proteomic analysis in a model of metabolic disease.
    Matsumura T, Suzuki T, Kada N, Aizawa K, Munemasa Y, Nagai R.
    Biochem Biophys Res Commun; 2006 Dec 29; 351(4):965-71. PubMed ID: 17097053
    [Abstract] [Full Text] [Related]

  • 10. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
    Opatrný K.
    Vnitr Lek; 2004 Jul 29; 50(7):556-63. PubMed ID: 15323265
    [Abstract] [Full Text] [Related]

  • 11. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Liu H, Hou X, Cheng J.
    Nephrology (Carlton); 2009 Apr 29; 14(3):332-7. PubMed ID: 19143942
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ, Cho EH, Yoo JH, Kim PK, Shin JS, Kim MR, Kim CW.
    J Proteome Res; 2007 Feb 29; 6(2):735-43. PubMed ID: 17269729
    [Abstract] [Full Text] [Related]

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 29; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 15. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP.
    Proteomics; 2005 Jul 29; 5(10):2648-55. PubMed ID: 15984045
    [Abstract] [Full Text] [Related]

  • 16. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H.
    J Diabetes Complications; 2005 Jul 29; 19(4):223-32. PubMed ID: 15993357
    [Abstract] [Full Text] [Related]

  • 17. Proteomics and diabetic retinopathy.
    Merchant ML, Klein JB.
    Clin Lab Med; 2009 Mar 29; 29(1):139-49. PubMed ID: 19389556
    [Abstract] [Full Text] [Related]

  • 18. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats.
    Gong D, Chen X, Middleditch M, Huang L, Vazhoor Amarsingh G, Reddy S, Lu J, Zhang S, Ruggiero K, Phillips AR, Cooper GJ.
    Proteomics; 2009 Sep 29; 9(18):4309-20. PubMed ID: 19634143
    [Abstract] [Full Text] [Related]

  • 19. Proteomics of mitochondrial inner and outer membranes.
    Distler AM, Kerner J, Hoppel CL.
    Proteomics; 2008 Oct 29; 8(19):4066-82. PubMed ID: 18763707
    [Abstract] [Full Text] [Related]

  • 20. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
    Zamora DO, Riviere M, Choi D, Pan Y, Planck SR, Rosenbaum JT, David LL, Smith JR.
    Mol Vis; 2007 Oct 30; 13():2058-65. PubMed ID: 18079679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.